Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$67.3 - $69.67 $8,008 - $8,290
-119 Reduced 1.3%
9,068 $631,000
Q2 2024

Aug 14, 2024

SELL
$66.47 - $69.65 $2.16 Million - $2.27 Million
-32,531 Reduced 77.98%
9,187 $617,000
Q1 2024

May 15, 2024

SELL
$56.67 - $69.36 $727,926 - $890,929
-12,845 Reduced 23.54%
41,718 $2.88 Million
Q4 2023

Feb 14, 2024

BUY
$49.38 - $63.75 $2.47 Million - $3.19 Million
50,057 Added 1110.9%
54,563 $3.4 Million
Q3 2023

Nov 14, 2023

SELL
$48.64 - $62.51 $1.14 Million - $1.46 Million
-23,432 Reduced 83.87%
4,506 $252,000
Q2 2023

Aug 14, 2023

SELL
$47.99 - $60.21 $14.6 Million - $18.4 Million
-304,909 Reduced 91.61%
27,938 $1.41 Million
Q1 2023

May 15, 2023

SELL
$52.6 - $67.34 $10.3 Million - $13.2 Million
-195,458 Reduced 37.0%
332,847 $18.2 Million
Q4 2022

Feb 14, 2023

SELL
$59.56 - $76.6 $56.8 Million - $73 Million
-952,821 Reduced 64.33%
528,305 $33 Million
Q3 2022

Nov 14, 2022

SELL
$57.96 - $78.12 $9.91 Million - $13.4 Million
-170,989 Reduced 10.35%
1,481,126 $104 Million
Q2 2022

Aug 15, 2022

BUY
$39.5 - $64.42 $10.1 Million - $16.4 Million
254,870 Added 18.24%
1,652,115 $93.6 Million
Q1 2022

May 16, 2022

BUY
$43.74 - $62.76 $10.8 Million - $15.5 Million
247,403 Added 21.52%
1,397,245 $87.5 Million
Q4 2021

Feb 14, 2022

BUY
$50.01 - $73.35 $12.1 Million - $17.7 Million
241,956 Added 26.65%
1,149,842 $64.4 Million
Q3 2021

Nov 15, 2021

BUY
$59.21 - $78.66 $4.62 Million - $6.14 Million
78,022 Added 9.4%
907,886 $59.1 Million
Q2 2021

Aug 16, 2021

BUY
$51.39 - $66.9 $42.2 Million - $54.9 Million
820,202 Added 8488.95%
829,864 $52.6 Million
Q1 2021

May 17, 2021

SELL
$49.14 - $59.89 $495,527 - $603,930
-10,084 Reduced 51.07%
9,662 $578,000
Q4 2020

Feb 12, 2021

BUY
$42.19 - $51.5 $78,937 - $96,356
1,871 Added 10.47%
19,746 $986,000
Q3 2020

Nov 16, 2020

SELL
$35.33 - $51.04 $177,179 - $255,965
-5,015 Reduced 21.91%
17,875 $913,000
Q2 2020

Aug 14, 2020

BUY
$22.91 - $39.83 $524,409 - $911,708
22,890 New
22,890 $804,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.